KRAS and lung carcinoma: Notably, there were three significantly concurrent pairs in the young lung cancer group (EGFR with concurrent RB1 and TP53; KRAS with concurrent PIK3CA) showed mutually exclusive in the old lung cancer group (Figures 3B, C).